Drug Profile
2' 2'-Difluorodeoxyguanosine
Alternative Names: dFdG; dFdGuoLatest Information Update: 21 Oct 1997
Price :
$50
*
At a glance
- Originator Eli Lilly and Company
- Class
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Oct 1997 No-Development-Reported for Cancer in USA (Unknown route)
- 08 Jun 1995 New profile
- 08 Jun 1995 Preclinical development for Cancer in USA (Unknown route)